Experiences of Bromelain-Based Enzymatic Debridement (Nexobrid) in Burn Patients: A Clinical Report

Early debridement (i.e., eschar removal) is regarded as a cornerstone for treating burn wounds. Although surgical the standard method complete removal of eschars, it has inefficiencies such blood loss, heat and poor selectivity, latter which means that both viable necrotic tissue are affected. To make up shortcomings, various alternative techniques have been developed. Nexobrid, mixture proteolytic enzymes with high bromelain content, emerged option in recent years due to its selectivity efficiency. This product enables dissolving without sacrificing or healthy tissue, preserving potential spontaneous epithelialization, accelerates wound healing leads better aesthetic outcomes Herein, we present our experience enzyme using Nexobrid.